Некоторые биофизические механизмы оптимизации внутрипузырной химиотерапии рака мочевого пузыря при воздействии сканирующего магнитного поля
А. И. Шихлярова, О. В. Тарнопольская, А. Н. Шевченко et al. · Международный журнал прикладных и фундаментальных исследований · 2014
In vitro experiments with isolated bladder cancer cells led to the conclusion of a significant accumulation of cations fluorochromes and cytostatic gemcitabine provided their magnetization modes scanning frequency from 1 to 150 Hz, the magnetic flux density of 20 mT. On the basis of these tests applied magnetic therapy to patients with non-invasive bladder cancer receiving adjuvant intravesical chemotherapy gemcitabine. A positive influence of a magnetic field to increase the bioavailability of chemotherapy to the tumor cells, it has been confirmed positive results in clinical trials on 30 patients who received exposure apparatus «Gradient-4M» during intravesical chemotherapy gemcitabine. Obtained by increasing the disease-free interval in 100 % of the study group patients and 17 ± 2 months vs. 6 ± 2 months (p = 0,046) in the control group, where recurrences were observed in 15 % of patients.
Cited by 0 works.